Ring Therapeutics
James Troia is a skilled engineering professional with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as a Senior Engineer at Ring Therapeutics since May 2021, James has previously held roles as Engineer II in Downstream Process Development and Automation Engineer at Repligen Corporation. Additionally, James has contributed to Regeneron as an Associate Project Engineer and Biotech Production Specialist from July 2017 to March 2020. James holds a Bachelor of Science degree in Chemical Engineering from Penn State University, earned in 2017.
Ring Therapeutics
Ring Therapeutics' Anellogy™ platform aims to usher in a new era of gene therapy using the human commensal virome.